| Jill Ann Bulambao Malazarte, RPT | |
|
105 Chester Rd, Springfield, VT 05156-2106 | |
| (802) 885-5741 | |
| Not Available |
| Full Name | Jill Ann Bulambao Malazarte |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 105 Chester Rd, Springfield, Vermont |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316311533 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 0400080856 (Vermont) | Primary |
| 225100000X | Physical Therapist | 009091 (Connecticut) | Secondary |
| Provider Name | Equipoise Occupational Therapy Pllc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1932772571 PECOS PAC ID: 1658775903 Enrollment ID: O20210809001291 |
News Archive
A new study suggests that children who typically receive an operation to insert ear tubes because of ear infections or fluid in the ear may not need it, according to clinical practice guidelines.
Britain's new, conservative-led coalition government says it will overhaul the national, government-financed health system by cutting back on the bureaucracy - to the tune of $30 billion between now and 2014 - and increasing funding for health services.
ImaginAb, Inc. and Imanet have signed a master service agreement for pre-clinical and clinical imaging. This agreement supports the development strategy for ImaginAb's pipeline of next generation diagnostic imaging agents based on recombinant antibody fragments. The Imanet™ network of Positron Emission Tomography (PET) imaging sites provides assistance in all aspects of PET imaging-based clinical trials: from proof-of-concept radiochemistry to clinical imaging, with more than 40 PET research tracers.
Genentech, a member of the Roche Group, today announced positive results from the Phase III IMpower130 study of Tecentriq (atezolizumab) plus chemotherapy (carboplatin and Abraxane® [albumin-bound paclitaxel; nab-paclitaxel]) for the initial (first-line) treatment of people with previously untreated metastatic non-squamous non-small cell lung cancer.
MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, announced today that it has signed a definitive agreement to acquire Stability Inc., d/b/a Stability Biologics, a provider of human tissue products to surgeons, facilities and distributors serving the surgical, spine and orthopedics sectors of the healthcare industry.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jill Ann Bulambao Malazarte, RPT 105 Chester Rd, Springfield, VT 05156-2106 Ph: (802) 885-5741 | Jill Ann Bulambao Malazarte, RPT 105 Chester Rd, Springfield, VT 05156-2106 Ph: (802) 885-5741 |
News Archive
A new study suggests that children who typically receive an operation to insert ear tubes because of ear infections or fluid in the ear may not need it, according to clinical practice guidelines.
Britain's new, conservative-led coalition government says it will overhaul the national, government-financed health system by cutting back on the bureaucracy - to the tune of $30 billion between now and 2014 - and increasing funding for health services.
ImaginAb, Inc. and Imanet have signed a master service agreement for pre-clinical and clinical imaging. This agreement supports the development strategy for ImaginAb's pipeline of next generation diagnostic imaging agents based on recombinant antibody fragments. The Imanet™ network of Positron Emission Tomography (PET) imaging sites provides assistance in all aspects of PET imaging-based clinical trials: from proof-of-concept radiochemistry to clinical imaging, with more than 40 PET research tracers.
Genentech, a member of the Roche Group, today announced positive results from the Phase III IMpower130 study of Tecentriq (atezolizumab) plus chemotherapy (carboplatin and Abraxane® [albumin-bound paclitaxel; nab-paclitaxel]) for the initial (first-line) treatment of people with previously untreated metastatic non-squamous non-small cell lung cancer.
MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, announced today that it has signed a definitive agreement to acquire Stability Inc., d/b/a Stability Biologics, a provider of human tissue products to surgeons, facilities and distributors serving the surgical, spine and orthopedics sectors of the healthcare industry.
› Verified 1 days ago
Karen Staniels, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 25 Ridgewood Rd, Sprinfield Medical Care System, Springfield, VT 05156 Phone: 802-885-7310 | |
Susan Lynn Langley, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 25 Ridgewood Rd, Springfield, VT 05156 Phone: 802-886-2172 | |
Mary Joyce Chalan, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 105 Chester Rd, Springfield, VT 05156 Phone: 802-885-5741 | |
Kevin Hill, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 100 River St, Springfield, VT 05156 Phone: 802-886-8920 Fax: 802-886-8929 | |
Mrs. Ana Lizza Lacambra Locsin, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 25 Ridgewood Rd, Springfield, VT 05156 Phone: 802-885-7310 | |
Andrea C Collins, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 266 River St, Springfield, VT 05156 Phone: 802-885-2151 |